The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.88
Bid: 40.56
Ask: 40.66
Change: -0.02 (-0.05%)
Spread: 0.10 (0.247%)
Open: 41.70
High: 41.70
Low: 40.50
Prev. Close: 40.90
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Interim CEO and director

3 Oct 2016 07:00

RNS Number : 4489L
Assura PLC
03 October 2016
 

Assura plc 

 

Appointment of Jonathan Murphy as Interim CEO and Andrew Darke as Property Director to the Board

 

The search process to appoint a new Chief Executive Officer for Assura is ongoing. While the process continues, Jonathan Murphy, currently the Finance Director, has been appointed Interim CEO to lead the business through this time as well as continuing with his responsibilities as Finance Director. Andrew Darke, Property Director, has also been appointed to the board, retaining responsibility for the property operations and developments. Simon Laffin, who has been Executive Chairman since March, will revert to his non-executive role.

 

Simon Laffin commented:

 

"We are focused on appointing the right person as CEO. I am delighted that Jonathan Murphy has agreed to take on the role on an interim basis and that Andrew Darke is joining the board. These appointments reflect the great work that they have both done over this transitional period."

 

Jonathan Murphy said:

 

"Assura continues to trade well with further strong growth as shown by today's trading update. I look forward to working with Andrew Darke on the board to ensure our continued success."

 

There is no information required to be disclosed pursuant to Listing Rule 9.6.13R in respect of Andrew Darke.

 

 

 - Ends-

 

For more information, please contact:

 

 

Assura plc

 

Tel: 01925 420660

Simon Laffin

Jonathan Murphy

 

 

Finsbury

 

Tel: 0207 251 3801

Gordon Simpson

 

 

Notes to Editors

 

On 4 March this year, Assura announced that Simon Laffin was becoming Executive Chairman to cover the absence of Graham Roberts, the CEO. This was further updated on 14 June, when it was announced that Graham was stepping down as CEO, and that Simon would remain as Executive Chairman whilst a process to appoint a new CEO was in process. On 4 July, the company announced that Graham had sadly passed away. 

 

Assura plc, a constituent of the FTSE 250, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington,

works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2016, Assura's property portfolio was valued at £1,111million.

 

 Further information is available at www.assuraplc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAFEFEEPKFAF
Date   Source Headline
16th Apr 20247:40 amRNSDirector/PDMR Shareholding
8th Apr 20244:34 pmRNSDirector/PDMR Shareholding
8th Apr 20247:00 amRNSScrip Dividend Declaration
22nd Mar 20242:18 pmRNSHolding(s) in Company
14th Mar 20248:30 amRNSScrip Calculation Price
6th Mar 20241:26 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSNotice of Dividend
8th Feb 20242:00 pmRNSCapital Markets Event
7th Feb 20242:33 pmRNSDirector/PDMR Shareholding
1st Feb 20249:32 amRNSTotal Voting Rights
16th Jan 20248:26 amRNSDirector/PDMR Shareholding
10th Jan 20247:00 amRNSTrading Update
9th Jan 20248:59 amRNSDirector/PDMR Shareholding
8th Jan 20247:00 amRNSScrip Dividend Declaration
21st Dec 20234:20 pmRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSScrip Calculation Price
6th Dec 20232:57 pmRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSNotice of Dividend
16th Nov 20237:00 amRNSAssura Plc Interim Results
8th Nov 20232:32 pmRNSDirector/PDMR Shareholding
1st Nov 20237:00 amRNSAppointment of Board Fellow
31st Oct 20237:00 amRNSNotice of Interim Results
31st Oct 20237:00 amRNSTotal Voting Rights
16th Oct 20232:04 pmRNSDirector/PDMR Shareholding
9th Oct 202311:13 amRNSDirector/PDMR Shareholding
9th Oct 20238:11 amRNSScrip Dividend Declaration
9th Oct 20237:00 amRNSRefinancing of RCF & new sustainability linkage
9th Oct 20237:00 amRNSTrading Update
18th Sep 20239:51 amRNSVesting and sale of restricted shares
14th Sep 20239:20 amRNSScrip Calculation Price
31st Aug 20237:00 amRNSNotice of Dividend
24th Aug 20238:36 amRNSHolding(s) in Company
8th Aug 20235:05 pmRNSDirector/PDMR Shareholding
31st Jul 20239:57 amRNSTotal Voting Rights
24th Jul 20237:00 amRNSDevelopment update
14th Jul 20231:47 pmRNSDirector/PDMR Shareholding
13th Jul 20234:47 pmRNSExercise of Nil Cost Options under PSP
12th Jul 20234:36 pmRNSDirector/PDMR Shareholding
10th Jul 202312:38 pmRNSHolding(s) in Company
10th Jul 20239:20 amRNSHolding(s) in Company
10th Jul 20237:00 amRNSScrip Dividend Declaration & Additional Listing
6th Jul 20232:47 pmRNSResult of AGM
6th Jul 202312:28 pmRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSTrading Update
3rd Jul 20237:00 amRNSChange of Registered Office
29th Jun 20234:46 pmRNSHolding(s) in Company
29th Jun 20237:00 amRNSCompletion of 100th development
27th Jun 20234:18 pmRNSHolding(s) in Company
27th Jun 20238:33 amRNSHolding(s) in Company
15th Jun 20237:31 amRNSScrip Calculation Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.